Clinical Trials at Inland Empire Liver Foundation
As of September 2026, 3 paid clinical trials are recruiting at Inland Empire Liver Foundation in Rialto, California. Active studies at this site cover conditions such as Hepatic Impairment, Non-alcoholic Fatty Liver Disease and AIH. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
3 clinical trials at Inland Empire Liver Foundation
·Clear filters·A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
Common conditions studied in Rialto
- Hepatic Impairment (3 active studies)
- Non-alcoholic Fatty Liver Disease (2 active studies)
- AIH (1 active study)
- Autoimmune Hepatitis (1 active study)
- Cirrhosis (1 active study)
- Crohn's Disease (1 active study)
Leading research sponsors in Rialto
- Amgen
- Boehringer Ingelheim
- 89bio, Inc.
- AstraZeneca
- GlaxoSmithKline
Frequently asked questions
How many paid clinical trials are currently recruiting in Rialto?
There are approximately 15 recruiting clinical trials in Rialto, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Rialto pay participants?
Most recruiting trials in Rialto compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Rialto?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Rialto?
The most common conditions under active study in Rialto include Hepatic Impairment (3), Non-alcoholic Fatty Liver Disease (2), AIH (1), Autoimmune Hepatitis (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Rialto?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Rialto on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Rialto?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Rialto?
Recruiting research sites in Rialto include Inland Empire Liver Foundation, Inland Empire Clinical Trials, LLC, 89bio Clinical Study Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Rialto right now?
The largest active categories in Rialto are Diabetes & metabolic (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.